AtriCure Inc Insider Trading
Every director, officer and 10% holder of AtriCure Inc has to report each trade in its stock within two business days of making it. This is those filings.
ATRC on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| Salvatore PriviteraChief Technical Officer2026-09-234.5K shat $60.00 | Sale10b5-1 plan | $271.1K |
| Regina E GrovesDirector2026-09-115.3K shat $54.22 | Sale | $288.1K |
| Salvatore PriviteraChief Technical Officer2026-09-083.7K shat $55.00 | Sale10b5-1 plan | $201.1K |
| Salvatore PriviteraChief Technical Officer2026-09-027.8K shat $52.50 | Sale10b5-1 plan | $407.6K |
| Karl S. DahlquistChief Legal Officer2026-08-249.4K shat $48.89 | Sale | $458.1K |
| Maggie YuenDirector2026-08-053.5K shat $38.42 | Sale | $134.5K |
| Karen PrangeDirector2026-08-053.6K shat $38.80 | Sale | $138.3K |
| Justin J NozneskyChief Mktg & Strategy Officer2026-07-296.2K shat $38.80 | Sale | $239.9K |
| Vinayak DoraiswamyChief Scientific Officer2026-07-286K shat $38.88 | Sale | $233.3K |
| Sven WehrweinDirector2026-07-2825K shat $37.84 | Sale | $946K |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on ATRC
Follow AtriCure Inc (ATRC) by email
New trades in AtriCure Inc (ATRC) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.